search Created with Sketch.
search Created with Sketch.

Advertisement

Group 35
Group 35

Scientifically Speaking: Botulinum Toxin Formulation and Testing

July 17, 2020

Joel L. Cohen, MD; and Conor Gallagher, PhD

Ever wonder about the differences in formulation and manufacture of botulinum neurotoxins? Curious about the trials that support approval? In this edition of Scientifically Speaking, Joel L. Cohen, MD gets the answers to these questions and more from Conor Gallagher, PhD, Head of Medical Affairs, Revance Therapeutics, Inc. 

Advertisement

Advertisement